{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:21:43Z","timestamp":1747207303846,"version":"3.40.5"},"reference-count":44,"publisher":"Bentham Science Publishers Ltd.","issue":"14","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Neglected tropical diseases (NTDs) are a global public health problem associated with approximately 20 conditions. Among these, Chagas disease (CD), caused by Trypanosoma cruzi, and human African trypanosomiasis (HAT), caused by T. brucei gambiense or T. brucei rhodesiense, affect mainly the populations of the countries from the American continent and sub-Saharan Africa. Pharmacological therapies used for such illnesses are not yet fully effective. In this context, the search for new therapeutic alternatives against these diseases becomes necessary. A drug design tool, recently recognized for its effectiveness in obtaining ligands capable of modulat-ing multiple targets for complex diseases, concerns molecular hybridization. Therefore, this review aims to demonstrate the importance of applying molecular hybridization in facing the challenges of developing prototypes as candidates for the treatment of parasitic diseases. Therefore, studies in-volving different chemical classes that investigated and used hybrid compounds in recent years were compiled in this work, such as thiazolidinones, naphthoquinones, quinolines, and others. Finally, this review covers several applications of the exploration of molecular hybridization as a potent strategy in the development of molecules potentially active against trypanosomiases, in order to provide information that can help in designing new drugs with trypanocidal activity.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389450123666220509202352","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T13:06:04Z","timestamp":1652274364000},"page":"1319-1329","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hybrid-Compounds Against Trypanosomiases"],"prefix":"10.2174","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1527-4501","authenticated-orcid":true,"given":"Edeildo","family":"Ferreira da Silva-J\u00fanior","sequence":"first","affiliation":[{"name":"Institute of Chemistry and Biotechnology, Federal University of Alagoas, 57072-970, Macei\u00f3, Brazil"},{"name":"Institute of Pharmaceutical Sciences, Federal University of Alagoas, 57072-970, Macei\u00f3, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica Alves","family":"Nunes","sequence":"additional","affiliation":[{"name":"Institute of Chemistry and Biotechnology, Federal University of Alagoas, 57072-970, Macei\u00f3, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7861\/clinmedicine.19-2-157","volume":"19","author":"Bodimeade C.","year":"2019","unstructured":"Bodimeade C.; Marks M.; Mabey D.; Neglected tropical diseases: Elimination and eradication. Clin Med (Northfield Il) 2019,19,157-160","journal-title":"Clin Med (Northfield Il)"},{"journal-title":"Neglected tropical diseases","author":"Moloo A.","key":"ref=2","unstructured":"Moloo A.;  Neglected tropical diseases Available from:  (Accessed on Dec 26, 2021)."},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40249-020-0630-9","volume":"9","author":"Engels D.","year":"2020","unstructured":"Engels D.; Zhou X-N.; Neglected tropical diseases: An effective global response to local poverty-related disease priorities. Infect Dis Poverty 2020,9(1),10","journal-title":"Infect Dis Poverty"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1039\/D0MD00122H","volume":"11","author":"Parthasarathy A.","year":"2020","unstructured":"Parthasarathy A.; Kalesh K.; Defeating the trypanosomatid trio: Proteomics of the protozoan parasites causing neglected tropical diseases. RSC Med Chem 2020,11(6),625-645","journal-title":"RSC Med Chem"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ijpddr.2019.11.004","volume":"12","author":"Ribeiro V.","year":"2020","unstructured":"Ribeiro V.; Dias N.; Paiva T.; Current trends in the pharmacological management of Chagas disease. Int J Parasitol Drugs Drug Resist 2020,12,7-17","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fpubh.2019.00166","volume":"7","author":"Lidani K.C.F.","year":"2019","unstructured":"Lidani K.C.F.; Andrade F.A.; Bavia L.; Chagas Disease: From Discovery to a Worldwide Health Problem. Front Public Health 2019,7,166","journal-title":"Front Public Health"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.3389\/fmicb.2018.02655","volume":"9","author":"Varikuti S.","year":"2018","unstructured":"Varikuti S.; Jha B.K.; Volpedo G.; Host-directed drug therapies for neglected tropical diseases caused by protozoan parasites. Front Microbiol 2018,9,2655","journal-title":"Front Microbiol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.2174\/1568026619666190619115735","volume":"19","author":"Ivasiv V.","year":"2019","unstructured":"Ivasiv V.; Albertini C.; Gon\u00e7alves A.E.; Rossi M.; Bolognesi M.L.; Molecular hybridization as a tool for designing multitarget drug candidates for complex diseases. Curr Top Med Chem 2019,19(19),1694-1711","journal-title":"Curr Top Med Chem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2174\/1385272823666191021124443","volume":"18","author":"Gontijo V.S.","year":"2020","unstructured":"Gontijo V.S.; Viegas F.P.D.; Ortiz C.J.C.; Molecular hybridization as a tool in the design of multi-target directed drug candidates for neurodegenerative diseases. Curr Neuropharmacol 2020,18(5),348-407","journal-title":"Curr Neuropharmacol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.bioorg.2019.01.045","volume":"86","author":"Holota S.","year":"2019","unstructured":"Holota S.; Kryshchyshyn A.; Derkach H.; Synthesis of 5-enamine-4-thiazolidinone derivatives with trypanocidal and anticancer activity. Bioorg Chem 2019,86,126-136","journal-title":"Bioorg Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1021\/jm010459j","volume":"45","author":"Du X.","year":"2002","unstructured":"Du X.; Guo C.; Hansell E.; Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain. J Med Chem 2002,45(13),2695-2707","journal-title":"J Med Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ejmech.2014.07.103","volume":"85","author":"Havrylyuk D.","year":"2014","unstructured":"Havrylyuk D.; Zimenkovsky B.; Karpenko O.; Grellier P.; Lesyk R.; Synthesis of pyrazoline-thiazolidinone hybrids with trypanocidal activity. Eur J Med Chem 2014,85,245-254","journal-title":"Eur J Med Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/cmdc.201300354","volume":"9","author":"Moreira D.R.M.","year":"2014","unstructured":"Moreira D.R.M.; Leite A.C.; Cardoso M.V.; Structural design, synthesis and structure-activity relationships of thiazolidinones with enhanced anti-Trypanosoma cruzi activity. ChemMedChem 2014,9(1),177-188","journal-title":"ChemMedChem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"13163","DOI":"10.1002\/slct.201902561","volume":"4","author":"Haroon M.","year":"2019","unstructured":"Haroon M.; Akhtar T.; Aline A.C.; Design, synthesis and in vitro trypanocidal and leishmanicidal activities of 2-(2-arylidene)hydrazono-4-oxothiazolidine-5-acetic acid derivatives. ChemistrySelect 2019,4,13163-13172","journal-title":"ChemistrySelect"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1128\/AAC.00038-08","volume":"52","author":"da Silva C.F.","year":"2008","unstructured":"da Silva C.F.; Batista M.M.; Batista D.G.; In vitro and in vivo. studies of the trypanocidal activity of a diarylthiophene diamidine against Trypanosoma cruzi. Antimicrob Agents Chemother 2008,52(9),3307-3314","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1002\/cmdc.200900098","volume":"4","author":"Patterson S.","year":"2009","unstructured":"Patterson S.; Jones D.C.; Shanks E.J.; Synthesis and evaluation of 1-(1-(Benzo[b]thiophen-2-yl)cyclohexyl)piperidine (BTCP) analogues as inhibitors of trypanothione reductase. ChemMedChem 2009,4(8),1341-1353","journal-title":"ChemMedChem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"4228","DOI":"10.1016\/j.bmc.2016.07.013","volume":"24","author":"Silva-J\u00fanior E.F.","year":"2016","unstructured":"Silva-J\u00fanior E.F.; Silva E.P.S.; Fran\u00e7a P.H.B.; Design, synthesis, molecular docking and biological evaluation of thiophen-2-iminothiazolidine derivatives for use against Trypanosoma cruzi. Bioorg Med Chem 2016,24(18),4228-4240","journal-title":"Bioorg Med Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1039\/C9MD00478E","volume":"11","author":"Georgiadis M-O.","year":"2019","unstructured":"Georgiadis M-O.; Kourbeli V.; Papanastasiou I.P.; Tsotinis A.; Taylor M.C.; Kelly J.M.; Synthesis and evaluation of novel 2,4-disubstituted arylthiazoles against T. brucei. RSC Med Chem 2019,11(1),72-84","journal-title":"RSC Med Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ejmech.2019.04.052","volume":"174","author":"Kryshchyshyn A.","year":"2019","unstructured":"Kryshchyshyn A.; Kaminskyy D.; Karpenko O.; Gzella A.; Grellier P.; Lesyk R.; Thiazolidinone\/thiazole based hybrids - New class of antitrypanosomal agents. Eur J Med Chem 2019,174,292-308","journal-title":"Eur J Med Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.1016\/j.bmc.2008.03.032","volume":"16","author":"da Silva J\u00fanior E.N.","year":"2008","unstructured":"da Silva J\u00fanior E.N.; de Souza M.C.B.V.; Fernandes M.C.; Synthesis and anti-Trypanosoma cruzi activity of derivatives from nor-lapachones and lapachones. Bioorg Med Chem 2008,16(9),5030-5038","journal-title":"Bioorg Med Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.1016\/j.bmc.2015.05.039","volume":"23","author":"Cardoso M.F.D.C.","year":"2015","unstructured":"Cardoso M.F.D.C.; Salom\u00e3o K.; Bomba\u00e7a A.C.; Synthesis and anti-Trypanosoma cruzi activity of new 3-phenylthio-nor-\u03b2-lapachone derivatives. Bioorg Med Chem 2015,23(15),4763-4768","journal-title":"Bioorg Med Chem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/cmdc.201800790","volume":"14","author":"Cerone M.","year":"2019","unstructured":"Cerone M.; Uliassi E.; Prati F.; Discovery of sustainable drugs for neglected tropical diseases: Cashew Nut Shell Liquid (CNSL)-based hybrids target mitochondrial function and ATP production in trypanosoma brucei. ChemMedChem 2019,14(6),621-635","journal-title":"ChemMedChem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"116213","DOI":"10.1016\/j.bmc.2021.116213","volume":"41","author":"Silva L.R.","year":"2021","unstructured":"Silva L.R.; Guimar\u00e3es A.S.; do Nascimento J.; Computer-aided design of 1,4-naphthoquinone-based inhibitors targeting cruzain and rhodesain cysteine proteases. Bioorg Med Chem 2021,41,116213","journal-title":"Bioorg Med Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1021\/jm900723w","volume":"53","author":"Fotie J.","year":"2010","unstructured":"Fotie J.; Kaiser M.; Delf\u00edn D.A.D.; Antitrypanosomal activity of 1,2-dihydroquinolin-6-ols and their ester derivatives. J Med Chem 2010,53(3),966-982","journal-title":"J Med Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.bmc.2012.11.009","volume":"21","author":"Gehrke S.S.","year":"2013","unstructured":"Gehrke S.S.; Pinto E.G.; Steverding D.; Conjugation to 4-aminoquinoline improves the anti-trypanosomal activity of Deferiprone-type iron chelators. Bioorg Med Chem 2013,21(3),805-813","journal-title":"Bioorg Med Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.ejmech.2015.07.018","volume":"101","author":"Coa J.C.","year":"2015","unstructured":"Coa J.C.; Castrill\u00f3n W.; Cardona W.; Synthesis, leishmanicidal, trypanocidal and cytotoxic activity of quinoline-hydrazone hybrids. Eur J Med Chem 2015,101,746-753","journal-title":"Eur J Med Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejmech.2015.05.044","volume":"100","author":"Leverrier A.","year":"2015","unstructured":"Leverrier A.; Bero J.; Cabrera J.; Fr\u00e9d\u00e9rich M.; Quetin-Leclercq J.; Palermo J.A.; Structure-activity relationship of hybrids of Cinchona alkaloids and bile acids with in vitro antiplasmodial and antitrypanosomal activities. Eur J Med Chem 2015,100,10-17","journal-title":"Eur J Med Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"5162","DOI":"10.1016\/j.bmc.2016.08.036","volume":"24","author":"Sola I.","year":"2016","unstructured":"Sola I.; Artigas A.; Taylor M.C.; Synthesis and biological evaluation of N-cyanoalkyl-, N-aminoalkyl-, and N-guanidinoalkyl-substituted 4-aminoquinoline derivatives as potent, selective, brain permeable antitrypanosomal agents. Bioorg Med Chem 2016,24(21),5162-5171","journal-title":"Bioorg Med Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"6995","DOI":"10.1016\/j.bmc.2008.05.038","volume":"16","author":"Porcal W.","year":"2008","unstructured":"Porcal W.; Hern\u00e1ndez P.; Boiani L.; New trypanocidal hybrid compounds from the association of hydrazone moieties and benzofuroxan heterocycle. Bioorg Med Chem 2008,16(14),6995-7004","journal-title":"Bioorg Med Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"5055","DOI":"10.1016\/j.ejmech.2009.09.009","volume":"44","author":"Castro D.","year":"2009","unstructured":"Castro D.; Boiani L.; Benitez D.; Anti-trypanosomatid benzofuroxans and deoxygenated analogues: Synthesis using polymer-supported triphenylphosphine, biological evaluation and mechanism of action studies. Eur J Med Chem 2009,44(12),5055-5065","journal-title":"Eur J Med Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ejmech.2014.05.077","volume":"82","author":"Massarico Serafim R.A.","year":"2014","unstructured":"Massarico Serafim R.A.; Gon\u00e7alves J.E.; de Souza F.P.; Design, synthesis and biological evaluation of hybrid bioisoster derivatives of N-acylhydrazone and furoxan groups with potential and selective anti-Trypanosoma cruzi activity. Eur J Med Chem 2014,82,418-425","journal-title":"Eur J Med Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1016\/j.ejmech.2010.01.052","volume":"45","author":"Gerpe A.","year":"2010","unstructured":"Gerpe A.; Boiani L.; Hern\u00e1ndez P.; Naftifine-analogues as anti-Trypanosoma cruzi agents. Eur J Med Chem 2010,45(6),2154-2164","journal-title":"Eur J Med Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/JPRI\/2018\/46885","volume":"25","author":"Freitas M da S.","year":"2019","unstructured":"Freitas M da S.; Torrecilhas A.C.; Xander P.; Vasconcelos C.I.; Menegon R.F.; Hybrid design as a strategy for development of trypanocidal drugs. J Pharm Res Int 2019,25(2),1-15","journal-title":"J Pharm Res Int"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1021\/jm101225g","volume":"54","author":"Ding D.","year":"2011","unstructured":"Ding D.; Meng Q.; Gao G.; Design, synthesis, and structure-activity relationship of Trypanosoma brucei leucyl-tRNA synthetase inhibitors as antitrypanosomal agents. J Med Chem 2011,54(5),1276-1287","journal-title":"J Med Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1021\/jm2012408","volume":"55","author":"Qiao Z.","year":"2012","unstructured":"Qiao Z.; Wang Q.; Zhang F.; Chalcone-benzoxaborole hybrid molecules as potent antitrypanosomal agents. J Med Chem 2012,55(7),3553-3557","journal-title":"J Med Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1021\/acsmedchemlett.9b00218","volume":"11","author":"Varghese S","year":"2019","unstructured":"Varghese S; Rahmani R; Russell S; Discovery of potent Nethylurea pyrazole derivatives as dual inhibitors of Trypanosoma brucei and Trypanosoma cruzi. ACS Med Chem Lett 2019,11(3),278-285","journal-title":"ACS Med Chem Lett"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"e02156","DOI":"10.1128\/AAC.02156-18","volume":"63","author":"de Ara\u00fajo JS","year":"2019","unstructured":"de Ara\u00fajo JS; Garc\u00eda-Rubia A; Sebasti\u00e1n-P\u00e9rez V; Imidazole derivatives as promising agents for the treatment of Chagas disease. Antimicrob Agents Chemother 2019,63(4),e02156-e18","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"111610","DOI":"10.1016\/j.ejmech.2019.111610","volume":"182","author":"Monteiro M.E.","year":"2019","unstructured":"Monteiro M.E.; Lechuga G.; Lara L.S.; Synthesis, structure-activity relationship and trypanocidal activity of pyrazole-imidazoline and new pyrazole-tetrahydropyrimidine hybrids as promising chemotherapeutic agents for Chagas disease. Eur J Med Chem 2019,182,111610","journal-title":"Eur J Med Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"10162","DOI":"10.1021\/jm501568b","volume":"57","author":"Vieira D.F.","year":"2014","unstructured":"Vieira D.F.; Choi J.Y.; Calvet C.M.; Binding mode and potency of N-indolyloxopyridinyl-4-aminopropanyl-based inhibitors targeting Trypanosoma cruzi CYP51. J Med Chem 2014,57(23),10162-10175","journal-title":"J Med Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"6989","DOI":"10.1021\/jm500448u","volume":"57","author":"Calvet C.M.","year":"2014","unstructured":"Calvet C.M.; Vieira D.F.; Choi J.Y.; 4-Aminopyridyl-based CYP51 inhibitors as anti-Trypanosoma cruzi drug leads with improved pharmacokinetic profile and in vivo potency. J Med Chem 2014,57(16),6989-7005","journal-title":"J Med Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ejmech.2017.09.064","volume":"141","author":"Otero E.","year":"2017","unstructured":"Otero E.; Garc\u00eda E.; Palacios G.; Triclosan-caffeic acid hybrids: Synthesis, leishmanicidal, trypanocidal and cytotoxic activities. Eur J Med Chem 2017,141,73-83","journal-title":"Eur J Med Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"9026","DOI":"10.1021\/acs.jmedchem.9b00294","volume":"62","author":"Boudreau P.D.","year":"2019","unstructured":"Boudreau P.D.; Miller B.W.; McCall L-I.; Design of gallinamide a analogs as potent inhibitors of the cysteine proteases human cathepsin L and Trypanosoma cruzi cruzain. J Med Chem 2019,62(20),9026-9044","journal-title":"J Med Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1021\/jm050922i","volume":"49","author":"Ravaschino E.L.","year":"2006","unstructured":"Ravaschino E.L.; Docampo R.; Rodriguez J.B.; Design, synthesis, and biological evaluation of phosphinopeptides against Trypanosoma cruzi targeting trypanothione biosynthesis. J Med Chem 2006,49(1),426-435","journal-title":"J Med Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1021\/jm031066i","volume":"47","author":"Dardonville C.","year":"2004","unstructured":"Dardonville C.; Rinaldi E.; Barrett M.P.; Brun R.; Gilbert I.H.; Hanau S.; Selective inhibition of Trypanosoma brucei 6-phosphogluconate dehydrogenase by high-energy intermediate and transition-state analogues. J Med Chem 2004,47(13),3427-3437","journal-title":"J Med Chem"}],"container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389450123666220509202352","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/204483\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389450123666220509202352","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T07:44:42Z","timestamp":1670744682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/204483\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":44,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389450123666220509202352","relation":{},"ISSN":["1389-4501"],"issn-type":[{"type":"print","value":"1389-4501"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-12-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}